Patent details

Basic Information

Publication number:

EP3464322

PCT Application Number:

IL2017050619

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177348398

PCT Publication Number:

WO2017212476

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL MOLECULES FOR THE TREATMENT OF INFLAMMATION

French Title of Invention:

NOUVELLES MOLÉCULES DESTINÉES AU TRAITEMENT DE L'INFLAMMATION

German Title of Invention:

NEUARTIGE MOLEKÜLE ZUR BEHANDLUNG VON ENTZÜNDUNGEN

SPC Number:

Dates

Filing date:

02/06/2017

Grant date:

05/04/2023

EP Publication Date:

10/04/2019

PCT Publication Date:

14/12/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/04/2023

EP B1 Publication Date:

05/04/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/06/2023

Expiration date:

02/06/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/03/2023

 

 

Name:

Tel HaShomer Medical Research Infrastructure and Services Ltd.

Address:

The Chaim Sheba Medical Center Tel HaShomer, 5262000 Ramat Gan, Israel (IL)

Inventor

1

Name:

MAGGIO, Nicola

Address:

Israel (IL)

2

Name:

SHAVIT STEIN, Efrat

Address:

Israel (IL)

3

Name:

CHAPMAN, Joab

Address:

Israel (IL)

Priority

Priority Number:

201662345802 P

Priority Date:

05/06/2016

Priority Country:

United States (US)

Classification

IPC classification:

C07K 7/06; A61K 38/48; C07K 14/755;

Publication

European Patent Bulletin

Issue number:

202314

Publication date:

05/04/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages